Global Orthopaedic Drug Market to Reach $44 Billion by 2010, Says New Report Available from Piribo.com

Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has just added to its collection a report on the global market for orthopaedic drugs. "The Worldwide Market for Prescription Orthopedic Drugs" (http://www.piribo.com/search/results.html?k=kal093&x=0&y=0) forecasts that the market will grow significantly in the next four years from 2005 market size of $26.8 billion.

(PRWEB) November 10, 2006 -- Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has just added to its collection a report on the global market for orthopaedic drugs. "The Worldwide Market for Prescription Orthopedic Drugs" (http://www.piribo.com/search/results.html?k=kal093&x=0&y=0) forecasts that the market will grow significantly in the next four years from 2005 market size of $26.8 billion.

According to the report, treatments for arthritis show the greatest potential for rapid growth, with sales expected to increase by 15.8%. 2006 sales are expected to grow by more than 25% over 2005, when sales fell from the previous year largely due to the withdrawal of Vioxx and Bextra from the market and the suspension of direct-to-consumer advertising of select products including Celebrex.

As the world's population continues to age, the demand for therapeutics to treat a wide range of orthopaedic conditions such as osteoporosis, Paget's disease, and other bone loss and growth disorders is mounting. Generics are creeping into some sectors which until recently were brand-only, heightening competitive pressures within the market. Yet the anticipated approval of many promising products leaves the market wide open for healthy growth.

The report discuses common orthopaedic diseases and conditions in general and provides detailed information on individual diseases and conditions and treatment approaches. Each segment provides an overview, world and U.S. prevalence of the various conditions, a detailed description of products on the market, products in the research and development pipeline, and market estimates and forecasts by geographical region (U.S. vs. non-U.S.) and by treatment type, including:

- NSAIDs and Cox-2 Inhibitors
- Antirheumatoids (DMARDS)
- SERMs
- Estrogen Combinations
- Bisphosphonates
- Calcitonins
- Polypeptide Hormones
- Sandostatin Analogs
- Skeletal Muscle Relaxants
- Pain Medications, and more

"The Worldwide Market for Prescription Orthopedic Drugs" is available in PDF format from Piribo. For more information, go to: http://www.piribo.com/publications/prescription_drugs/world_market_prescription_orthopedic_drugs.html

About Piribo
Piribo is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 5,500 English language titles including, market reports, studies and books and is the UK's largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.

###

Press Contact: BRENDT SHEEN
Company Name: Piribo
Email: email protected from spam bots
Phone: 02070607474
Website: http://www.piribo.com/publications/prescription_drugs/world_market_prescription_orthopedic_drugs.htm

¶ 10:45 AM